3,253 hedge funds and large institutions have $222B invested in Pfizer in 2021 Q4 according to their latest regulatory filings, with 587 funds opening new positions, 1,251 increasing their positions, 1,152 reducing their positions, and 85 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding in top 10

Funds holding in top 10:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding:

9% more repeat investments, than reductions

Existing positions increased: 1,251 | Existing positions reduced: 1,152

1% more call options, than puts

Call options by funds: $5.34B | Put options by funds: $5.26B

0.97% more ownership

Funds ownership: 66.27%67.24% (+0.97%)

Holders
3,253
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
249
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$5.34B
Puts
$5.26B
Net Calls
Net Calls Change

Top Buyers

1 +$517M
2 +$511M
3 +$381M
4
JP Morgan Chase
JP Morgan Chase
New York
+$314M
5
Two Sigma Advisers
Two Sigma Advisers
New York
+$271M
Name Holding Trade Value Shares
Change
Change in
Stake
2126
$966K
2127
$966K
2128
$966K
2129
$965K
2130
$964K
2131
$963K
2132
$962K
2133
$961K
2134
$960K
2135
$960K
2136
$959K
2137
$956K
2138
$955K
2139
$952K
2140
$949K
2141
$947K
2142
$946K
2143
$945K
2144
$945K
2145
$942K
2146
$941K
2147
$934K
2148
$933K
2149
$933K
2150
$931K